[Study on the influence factors of the serum fibrosis markers]
- PMID: 12546736
[Study on the influence factors of the serum fibrosis markers]
Abstract
Objective: To analyse the factors which influence the four serum fibrosis markers hyaluronic acid (HA), type III procollagen (PCIII), laminin (LN) and type IV collagen (CIV).
Methods: The levels of serum HA, PCIII, LN and CIV were measured by RIA in 141 patients with chronic hepatitis B (CHB), then the patients were divided into two groups according to the serum fibrosis markers, namely consistent group and inconsistent group. the liver biopsy materials were examined pathomorphologically and liver function was detected by automatic biochemistry analyzer, The interior diameters of the portal vein, the spleen vein and the thickness of the spleen were also measured with ultrasonography.
Results: 16 patients (14.16%) whose serum fibrosis markers were inconsistent with histological stage of liver fibrosis were found. Their serum fibrosis markers were not correlated with staging of liver fibrosis (P>0.05), but were positively correlated with inflammation grade (x(2)=12.07, P<0.05), at same time, the serum levels of alanine aminotransferase (ALT), aspartate aminotransferase(AST), gamma-glutamyltransferase (GGT) and globulin (GLB) decreased obviously, from 89.28 U/L +/- 64.25 U/L to 49.31 U/L +/- 26.75 U/L (t=2.45, P<0.05), 66.10 U/L +/- 42.30 U/L to 40.83 U/L +/- 22.40 U/L (t=2.33, P<0.05), 86.26 U/L +/- 70.36 U/L to 48.99 U/L +/- 29.96 U/L (t=2.08, P<0.05) and 32.13 g/L +/- 5.18 g/L to 28.05 g/L +/- 3.47 g/L (t=3.03, P<0.01) respectively. And the level of albumin (ALB) and the ratio of albumin and globulin (A/G) increased evidently, from 42.34 g/L +/- 4.81 g/L to 46.19 g/L +/- 3.61 g/L (t=3.06, P<0.01) and 1.35 +/- 0.28 to 1.63 +/- 0.26 (t=3.70, P<0.01). But the serum level of alkaline phosphatase (ALP), total bilirubin (TBil), total protein (TP), the width of main portal vein, the width of splenic vein and the thickness of the spleen did not change clearly (P>0.05).
Conclusion: As diagnostic markers, serum fibrosis markers as well as inflammation grade and liver function should be taken into account.
Similar articles
-
[Diagnostic value of five serum markers for liver fibrosis].Zhonghua Gan Zang Bing Za Zhi. 2001 Jun;9(3):148-50. Zhonghua Gan Zang Bing Za Zhi. 2001. PMID: 11412388 Chinese.
-
Influence factors of serum fibrosis markers in liver fibrosis.World J Gastroenterol. 2003 Nov;9(11):2497-500. doi: 10.3748/wjg.v9.i11.2497. World J Gastroenterol. 2003. PMID: 14606083 Free PMC article.
-
The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.Hepatobiliary Pancreat Dis Int. 2002 May;1(2):202-6. Hepatobiliary Pancreat Dis Int. 2002. PMID: 14607739
-
Efficacy and safety of Fufang Biejia Ruangan Tablets as an adjuvant treatment for chronic hepatitis B liver fibrosis: A systematic review and meta-analysis.Medicine (Baltimore). 2022 Nov 18;101(46):e31664. doi: 10.1097/MD.0000000000031664. Medicine (Baltimore). 2022. PMID: 36401442 Free PMC article.
-
[Pathogenesis of alcoholic chronic hepatitis].Nihon Arukoru Yakubutsu Igakkai Zasshi. 2014 Oct;49(5):219-26. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2014. PMID: 25651616 Review. Japanese.
Cited by
-
Abnormal liver function in different patients with Schistosoma japonicum.Parasitol Res. 2015 Jan;114(1):85-90. doi: 10.1007/s00436-014-4163-7. Epub 2014 Oct 8. Parasitol Res. 2015. PMID: 25287714
-
Correlation of serum liver fibrosis markers with severity of liver dysfunction in liver cirrhosis: a retrospective cross-sectional study.Int J Clin Exp Med. 2015 Apr 15;8(4):5989-98. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26131195 Free PMC article.
-
Study of transactivating effect of pre-S2 protein of hepatitis B virus and cloning of genes transactivated by pre-S2 protein with suppression subtractive hybridization.World J Gastroenterol. 2005 Sep 21;11(35):5438-43. doi: 10.3748/wjg.v11.i35.5438. World J Gastroenterol. 2005. PMID: 16222733 Free PMC article.
-
Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis.World J Gastroenterol. 2003 Nov;9(11):2490-6. doi: 10.3748/wjg.v9.i11.2490. World J Gastroenterol. 2003. PMID: 14606082 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous